Mental and behavioural disorders due to psychoctive substance use

F5_SUBSTANCE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

19672

diagram downward connector
F5_SUBSTANCE

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 19028 6718 12310
Unadjusted prevalence (%) 6.17 3.87 9.12
Mean age at first event (years) 44.52 41.30 46.28

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.07 5.51 [4.59, 6.62] 2.4e-74 3170
15 years 0.02 3.26 [2.81, 3.77] 1.6e-55 1245
5 years 0.01 5.82 [5.16, 6.56] <1e-100 734
1 year 0.00 27.23 [23.71, 31.27] <1e-100 711

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: F5_SUBSTANCE – Mental and behavioural disorders due to psychoctive substance use
GWS hits: 5

Survival analyses between endpoints

Plot

before Mental and behavioural disorders due to psychoctive substance use
after Mental and behavioural disorders due to psychoctive substance use

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Mental and behavioural disorders due to psychoctive substance use